Cinctive Capital Management LP Horizon Therapeutics Public LTD CO Transaction History

Cinctive Capital Management LP

$2.1 Billion
Q1 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$98.98 - $115.74 $2.61 Million - $3.05 Million	-26,389 Reduced 9.95%	238,812 $27.6 Million
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $4.26 Million - $4.97 Million	44,201 Added 20.0%	265,201 $27.3 Million
Q1 2023 May 15, 2023	BUY	$107.32 - $113.5 $11.4 Million - $12 Million	106,000 Added 92.17%	221,000 $24.1 Million
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $7.17 Million - $13.1 Million	115,000 New	115,000 $13.1 Million
Q2 2022 Aug 15, 2022	SELL	$79.4 - $116.36 $11 Million - $16.1 Million	-138,341 Closed	0 $0

Q1 2022 May 16, 2022	BUY	$86.42 - $109.81 $114,333 - $145,278	1,323 Added 0.97%	138,341 $14.6 Million
Q4 2021 Feb 14, 2022	SELL	$98.56 - $119.91 $1.4 Million - $1.7 Million	-14,217 Reduced 9.4%	137,018 $14.8 Million
Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $698,975 - $839,363	7,605 Added 5.29%	151,235 $16.6 Million
Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $11.3 Million - $12.6 Million	130,935 Added 1031.39%	143,630 $13.5 Million
Q1 2021 May 17, 2021	BUY	$71.83 - $95.48 $911,881 - $1.21 Million	12,695 New	12,695 $1.17 Million
Q4 2020 Feb 16, 2021	SELL	$67.0 - $84.39 $5.4 Million - $6.8 Million	-80,595 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$55.23 - $79.93 $1.92 Million - $2.78 Million	-34,723 Reduced 30.11%	80,595 $6.26 Million
Q2 2020 Aug 14, 2020	SELL	$30.2 - $56.98 $1.01 Million - $1.91 Million	-33,518 Reduced 22.52%	115,318 $6.41 Million
Q1 2020 May 15, 2020	SELL	$24.87 - $38.56 $899,398 - $1.39 Million	-36,164 Reduced 19.55%	148,836 $4.41 Million
Q4 2019 Feb 14, 2020	BUY	$25.43 - $36.67 $4.7 Million - $6.78 Million	185,000 New	185,000 $6.7 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Cinctive Capital Management LP with notifications on news.

Account